13.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché RDY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$14.22
Aprire:
$13.97
Volume 24 ore:
1.30M
Relative Volume:
0.84
Capitalizzazione di mercato:
$11.64B
Reddito:
$3.85B
Utile/perdita netta:
$667.93M
Rapporto P/E:
21.22
EPS:
0.657
Flusso di cassa netto:
$142.30M
1 W Prestazione:
-4.98%
1M Prestazione:
-6.69%
6M Prestazione:
+0.87%
1 anno Prestazione:
-15.55%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Confronta RDY con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RDY
Dr Reddys Laboratories Ltd Adr
|
13.94 | 11.84B | 3.85B | 667.93M | 142.30M | 0.657 |
![]()
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 29.98B | 958.27M | 5.31B | 0.2964 |
![]()
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-05 | Aggiornamento | HSBC Securities | Hold → Buy |
2024-12-19 | Downgrade | Nomura | Buy → Neutral |
2024-01-11 | Downgrade | Jefferies | Buy → Underperform |
2023-08-29 | Downgrade | HSBC Securities | Buy → Hold |
2023-05-18 | Downgrade | Bernstein | Outperform → Mkt Perform |
2023-03-17 | Aggiornamento | BofA Securities | Neutral → Buy |
2023-01-30 | Iniziato | JP Morgan | Underweight |
2022-11-14 | Downgrade | Credit Suisse | Neutral → Underperform |
2022-01-03 | Ripresa | BofA Securities | Neutral |
2021-07-27 | Downgrade | Credit Suisse | Outperform → Neutral |
2021-02-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
2020-09-18 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-09-18 | Aggiornamento | Investec | Sell → Hold |
2020-01-28 | Downgrade | CLSA | Buy → Outperform |
2020-01-27 | Downgrade | CLSA | Buy → Outperform |
2020-01-09 | Aggiornamento | Citigroup | Sell → Buy |
2019-11-04 | Downgrade | BofA/Merrill | Buy → Neutral |
2019-09-04 | Aggiornamento | Credit Suisse | Underperform → Outperform |
2019-07-01 | Aggiornamento | Macquarie | Neutral → Outperform |
2019-06-20 | Iniziato | Deutsche Bank | Hold |
2019-06-11 | Iniziato | Barclays | Equal Weight |
2019-05-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-02-19 | Aggiornamento | CLSA | Outperform → Buy |
2019-01-17 | Downgrade | Citigroup | Neutral → Sell |
2017-09-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2017-08-31 | Aggiornamento | CLSA | Underperform → Outperform |
2017-07-28 | Downgrade | CLSA | Underperform → Sell |
2016-07-27 | Downgrade | HSBC Securities | Hold → Reduce |
2016-07-27 | Downgrade | Jefferies | Hold → Underperform |
2016-02-10 | Aggiornamento | Credit Agricole | Underperform → Buy |
2015-11-10 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Dr Reddys Laboratories Ltd Adr Borsa (RDY) Ultime notizie
Asian ADRs Fall As Winners And Losers Stand Out - Finimize
Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options - GlobeNewswire Inc.
Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 25% Tariff On India - MSN
Asian ADRs Falter On US Markets As Fintechs Slide - Finimize
NVO Stock Quote Price and Forecast - CNN
Asian Stocks Listed In The US Kicked Off The Week Lower - Finimize
Validea's Top Health Care Stocks Based On Peter Lynch7/28/2025 - Nasdaq
Asian Stocks Dipped As US-Listed ADRs Edged Lower - Finimize
Stock Picks Today: Infosys, Dr. Reddys Labs, Kajaria Ceramics, Tata Consumer Products On Brokerages Radar - NDTV Profit
Dr Reddy's Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - MSN
Dr. Reddy’s Labs ADR earnings missed, revenue fell short of estimates - Investing.com Australia
India's Dr Reddy's says open to boosting U.S. manufacturing as tariff threat looms - sg.finance.yahoo.com
Asian Stocks Mixed As S&P Asia 50 ADR Index Falls - Finimize
Dr Reddys Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - NDTV Profit
LLY Stock Quote Price and Forecast - CNN
HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - MSN
Asian ADRs Retreat As Mixed Results Hit The Market - Finimize
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Morgan Stanley initiates coverage on Dr. Reddy’s stock with Equalweight rating - Investing.com India
Dr Reddy's Laboratories among four key stocks to trade ex-dividend today - Mint
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
Dr. Reddys Labs, Diffusion Engineers, LMW Wheels India Dividends — Last Day To Buy - NDTV Profit
Macquarie downgrades Dr. Reddy’s stock rating to Neutral on gRevlimid concerns - Investing.com India
Mixed Movements In Asian Equities As Some Sectors Shine - Finimize
Full Truck Alliance Co. Ltd. Sponsored ADR (NYSE:YMM) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World
Mather Group LLC. Buys 3,413 Shares of Haleon PLC Sponsored ADR (NYSE:HLN) - Defense World
Stock Traders Buy High Volume of VNET Group Call Options (NASDAQ:VNET) - Defense World
Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Holdings Cut by Robeco Institutional Asset Management B.V. - MarketBeat
Asian Equities Traded in the US as ADRs Rise in Thursday Trading - 富途牛牛
Growth to continue despite macro tensions: Infosys Chairman Nandan Nilekani - Business Standard
Asian ADRs Climb With North And South Leaders - Finimize
Dr Reddy’s Breaks Past ₹1,330 Apex: SEBI RA Rajneesh Sharma Sees Trend Shift, Cautions Overbought Zone - Investing.com India
Dr Reddys Laboratories allots Equity shares - Business Standard
RDY’s Market Whiplash: 2.41% YTD Rise, 14.68% Rise in 30 Days - investchronicle.com
SBI Cards to WiproPrashanth Tapse suggests stocks to buy in the short term - Mint
Stocks Showing Rising Market Leadership: Dr. Reddy's Labs ADR Earns 81 RS Rating - Investor's Business Daily
Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize
Dr Reddys Laboratories Ltd Adr Azioni (RDY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):